DYN Dyne Therapeutics, Inc. - Common Stock
DYN Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
DYN Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
DYN Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
- Acquisto forte 7 33,3%
- Compra 12 57,1%
- Mantieni 2 9,5%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
15 analisti · 2026-08-15Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-1.08 | $-0.76 | -0.32% |
| 31 Marzo 2026 | $-0.73 | $-0.78 | 0.05% |
| 31 Dicembre 2025 | $-0.76 | $-0.78 | 0.02% |
| 30 Settembre 2025 | $-0.76 | $-0.85 | 0.09% |
| 30 Giugno 2025 | $-0.97 | $-0.96 | -0.01% |
| 31 Marzo 2025 | $-1.05 | $-0.89 | -0.16% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| PBLS | — | — | — | — | — | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $398M | $281M | $211M | $143M | $121M | $45M | $11M | |
| SG&A Expense | $70M | $62M | $31M | $28M | $29M | $13M | $3M | |
| Operating Expenses | $468M | $344M | $242M | $171M | $150M | $59M | $14M | |
| Operating Income | $-468M | $-344M | $-242M | $-171M | $-150M | $-59M | $-14M | |
| Other Non-op | $22M | $26M | $6M | $3M | $734.0K | $-790.0K | $-1M | |
| Income Tax | $0 | $0 | $0 | · | · | · | · | |
| Net Income | $-446M | $-317M | $-236M | $-168M | $-149M | $-59M | $-15M | |
| EPS (Basic) | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 | · | · | |
| EPS (Diluted) | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 | · | · | |
| EBITDA | $-466M | $-342M | $-240M | $-169M | $-149M | $-58M | · |
Stato Patrimoniale 20
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $893M | $435M | $122M | $172M | $201M | $301M | $15M | |
| Prepaid Expense | $16M | $17M | $6M | $10M | $6M | $4M | $127.0K | |
| Current Assets | $1.13B | $659M | $129M | $266M | $382M | $349M | $15M | |
| PP&E (Net) | $24M | $5M | $5M | $6M | $5M | $2M | $1M | |
| PP&E (Gross) | $33M | $12M | $10M | $10M | $7M | $3M | $2M | |
| Accum. Depreciation | $9M | $7M | $5M | $4M | $2M | $995.0K | $295.0K | |
| Other Non-current Assets | · | · | · | · | · | · | $191.0K | |
| Total Assets | $1.19B | $691M | $165M | $306M | $426M | $353M | $16M | |
| Accounts Payable | $8M | $7M | $23M | $5M | $4M | $3M | $1M | |
| Current Liabilities | $51M | $42M | $51M | $28M | $29M | $11M | $2M | |
| Capital Leases | $15M | $19M | $23M | $26M | $29M | $0 | · | |
| Total Liabilities | $215M | $61M | $74M | $54M | $57M | $11M | $2M | |
| Long-term Debt | $149M | $0 | · | · | · | · | · | |
| Common Stock | $16.0K | $10.0K | $6.0K | $6.0K | $6.0K | $5.0K | $1.0K | |
| Paid-in Capital | $2.37B | $1.58B | $724M | $650M | $597M | $422M | $6M | |
| Retained Earnings | $-1.40B | $-950M | $-633M | $-397M | $-228M | $-79M | $-20M | |
| AOCI | $475.0K | $6.0K | $0 | $-571.0K | $-269.0K | $-27.0K | · | |
| Stockholders' Equity | $972M | $630M | $91M | $252M | $368M | $342M | $14M | |
| Liabilities + Equity | $1.19B | $691M | $165M | $306M | $426M | $353M | $16M | |
| Shares Outstanding | 164,950,540 | 102,318,629 | 61,468,743 | 55,636,505 | 51,569,381 | 45,076,574 | 2,586,535 |
Flusso di cassa 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $1M | $700.0K | $271.0K | |
| Stock-based Comp | $46M | $46M | $20M | $15M | $18M | $7M | $26.0K | |
| Other Non-cash | $-5M | $-22M | $26M | $-2M | $11M | $6M | · | |
| Operating Cash Flow | $-403M | $-292M | $-188M | $-154M | $-120M | $-47M | $-12M | |
| CapEx | $2M | $2M | $729.0K | $3M | $4M | $1M | $2M | |
| Investing Cash Flow | $-29M | $-204M | $83M | $87M | $-138M | $-46M | $-2M | |
| Debt Issued | $148M | $0 | $0 | · | · | $10M | · | |
| Net Debt Issued | $148M | · | · | · | · | $10M | · | |
| Stock Issued | $141M | $98M | $52M | $37M | · | · | · | |
| Net Stock Activity | $141M | $98M | · | · | · | · | · | |
| Financing Cash Flow | $890M | $810M | $54M | $37M | $158M | $381M | $20M | |
| Net Change in Cash | $458M | $313M | $-51M | $-29M | $-100M | $289M | $7M | |
| Free Cash Flow | $-405M | $-295M | $-189M | $-157M | $-123M | $-48M | · |
Redditività 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -47.5% | -74.1% | -100.1% | -45.9% | -38.3% | -32.1% | · | |
| ROE | -57.8% | -47.5% | -193.9% | -67.0% | -38.2% | -16.8% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.3 | 15.6 | 2.5 | 9.5 | 13.3 | 31.8 | · | |
| Quick Ratio | 17.6 | 10.3 | 2.4 | 6.1 | 7.0 | 27.4 | · |
Valutazione (TTM) 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-446M | $-317M | $-236M | $-168M | $-149M | $-59M | · | |
| Market Cap | $3.23B | $2.41B | $818M | $645M | $613M | $947M | · | |
| P/E | -5.6 | -7.0 | -3.4 | -3.6 | -4.1 | · | · | |
| P/B | 3.3 | 3.8 | 9.0 | 2.6 | 1.7 | 2.8 | · | |
| P / Tangible Book | 3.3 | 3.8 | 9.0 | 2.6 | 1.7 | 2.8 | · | |
| P / Cash Flow | -8.0 | -8.2 | -4.3 | -4.2 | -5.1 | -20.4 | · | |
| P / FCF | -8.0 | -8.2 | -4.3 | -4.1 | -5.0 | -19.9 | · | |
| Earnings Yield | -17.7% | -14.3% | -29.7% | -27.9% | -24.6% | · | · |
Conto Economico 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $152M | $101M | $95M | $97M | $99M | $106M | $82M | $93M | $62M | $45M | $55M | $59M | $38M | $35M | $47M | $28M | |
| SG&A Expense | $29M | $24M | $21M | $17M | $17M | $16M | $15M | $13M | $10M | $25M | $7M | $8M | $8M | $8M | $6M | $8M | |
| Operating Expenses | $182M | $125M | $116M | $114M | $116M | $122M | $97M | $106M | $72M | $69M | $62M | $67M | $45M | $42M | $53M | $36M | |
| Operating Income | $-182M | $-125M | $-116M | $-114M | $-116M | $-122M | $-97M | $-106M | $-72M | $-69M | $-62M | $-67M | $-45M | $-42M | $-53M | $-36M | |
| Interest Expense | · | · | · | $3M | $94.0K | · | · | $0 | · | · | · | · | · | · | · | · | |
| Other Non-op | $3M | $4M | $4M | $6M | $5M | $7M | $8M | $9M | $7M | $4M | $2M | $2M | $1M | $894.0K | $451.0K | $200.0K | |
| Net Income | $-179M | $-121M | $-112M | $-108M | $-111M | $-115M | $-90M | $-97M | $-65M | $-66M | $-60M | $-65M | $-44M | $-41M | $-52M | $-36M | |
| EPS (Basic) | $-1.08 | $-0.73 | $-0.69 | $-0.76 | $-0.97 | $-1.05 | $-0.90 | $-0.96 | $-0.70 | $-0.81 | $-0.99 | $-1.08 | $-0.78 | $-0.80 | $-1.01 | $-0.69 | |
| EPS (Diluted) | $-1.08 | $-0.73 | $-0.69 | $-0.76 | $-0.97 | $-1.05 | $-0.90 | $-0.96 | $-0.70 | $-0.81 | $-0.99 | $-1.08 | $-0.78 | $-0.80 | $-1.01 | $-0.69 | |
| EBITDA | $-181M | $-125M | · | $-113M | $-115M | $-122M | · | $-105M | $-72M | $-69M | $-62M | $-66M | $-45M | $-42M | $-52M | $-35M |
Stato Patrimoniale 19
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $753M | $893M | $574M | $485M | $472M | $435M | $532M | $608M | $272M | $130M | $168M | $181M | $145M | $136M | $148M | |
| Prepaid Expense | $39M | $49M | $16M | $14M | $14M | $12M | $17M | $13M | $13M | $35M | $10M | $5M | $11M | $10M | $6M | $21M | |
| Current Assets | $938M | $1.02B | $1.13B | $806M | $698M | $690M | $659M | $736M | $792M | $488M | $168M | $213M | $249M | $258M | $298M | $344M | |
| PP&E (Net) | $25M | $24M | $24M | $24M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $5M | $6M | |
| PP&E (Gross) | $34M | $33M | $33M | $32M | $13M | $13M | $12M | $11M | $11M | $10M | $10M | $10M | $10M | $9M | $8M | $8M | |
| Accum. Depreciation | $10M | $9M | $9M | $8M | $8M | $7M | $7M | $7M | $6M | $6M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Total Assets | $994M | $1.08B | $1.19B | $867M | $729M | $721M | $691M | $769M | $826M | $522M | $205M | $251M | $289M | $300M | $340M | $388M | |
| Accounts Payable | $12M | $11M | $8M | $12M | $14M | $7M | $7M | $6M | $2M | $7M | $4M | $3M | $9M | $919.0K | $7M | $5M | |
| Current Liabilities | $78M | $51M | $51M | $60M | $41M | $34M | $42M | $43M | $30M | $22M | $30M | $20M | $22M | $23M | $26M | $23M | |
| Capital Leases | $15M | $14M | $15M | $16M | $17M | $18M | $19M | $20M | $21M | $22M | $24M | $24M | $25M | $27M | $27M | $28M | |
| Total Liabilities | $292M | $215M | $215M | $175M | $158M | $52M | $61M | $63M | $51M | $44M | $53M | $45M | $47M | $50M | $53M | $51M | |
| Long-term Debt | $199M | $149M | $149M | $99M | $99M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Common Stock | $16.0K | $16.0K | $16.0K | $14.0K | $11.0K | $11.0K | $10.0K | $10.0K | $10.0K | $9.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $2.40B | $2.38B | $2.37B | $1.98B | $1.75B | $1.73B | $1.58B | $1.57B | $1.54B | $1.18B | $718M | $713M | $683M | $608M | $605M | $601M | |
| Retained Earnings | $-1.70B | $-1.52B | $-1.40B | $-1.28B | $-1.18B | $-1.07B | $-950M | $-860M | $-763M | $-698M | $-566M | $-506M | $-441M | $-358M | $-316M | $-264M | |
| AOCI | $-353.0K | $-137.0K | $475.0K | $496.0K | $252.0K | $241.0K | $6.0K | $478.0K | $-240.0K | $-132.0K | $-13.0K | $-56.0K | $-203.0K | $-983.0K | $-1M | $-930.0K | |
| Stockholders' Equity | $702M | $865M | $972M | $692M | $571M | $669M | $630M | $706M | $775M | $478M | $152M | $207M | $242M | $250M | $287M | $336M | |
| Liabilities + Equity | $994M | $1.08B | $1.19B | $867M | $729M | $721M | $691M | $769M | $826M | $522M | $205M | $251M | $289M | $300M | $340M | $388M | |
| Shares Outstanding | 165,670,880 | 165,201,329 | 164,950,540 | 142,613,248 | 114,338,610 | 113,633,782 | 102,318,629 | 101,753,378 | 100,119,518 | 87,089,649 | 61,322,283 | 61,013,986 | 58,305,480 | 51,906,773 | 51,734,361 | 51,649,423 |
Flusso di cassa 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $600.0K | $550.0K | $547.0K | $500.0K | $500.0K | $502.0K | $487.0K | $400.0K | $400.0K | $386.0K | $400.0K | $400.0K | $412.0K | $400.0K | $500.0K | $425.0K | |
| Stock-based Comp | $15M | $13M | $11M | $11M | $11M | $13M | $10M | $9M | $7M | $20M | $5M | $5M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | $-38M | · | · | · | $-4M | · | · | · | $-33M | · | · | $-8M | · | · | $-20M | |
| Operating Cash Flow | $-130M | $-145M | $-112M | $-91M | $-95M | $-106M | $-84M | $-75M | $-55M | $-79M | $-51M | $-56M | $-47M | $-43M | $-31M | $-51M | |
| CapEx | $2M | $221.0K | $484.0K | $395.0K | $60.0K | $981.0K | $1M | $253.0K | $857.0K | $191.0K | $167.0K | $250.0K | $230.0K | $886.0K | $261.0K | $1M | |
| Investing Cash Flow | $-5M | $-2M | $982.0K | $-38M | $7M | $1M | $-16M | $-19M | $11M | $-180M | $13M | $17M | $27M | $52M | $18M | $-2M | |
| Debt Issued | · | · | $49M | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $141M | $0 | $0 | $24M | $74M | $0 | $24M | $28M | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $141M | · | · | · | $74M | · | · | · | · | · | · | |
| Financing Cash Flow | $58M | $7M | $431M | $217M | $101M | $141M | $4M | $18M | $380M | $408M | $454.0K | $25M | $29M | $70.0K | $99.0K | $18.0K | |
| Net Change in Cash | $-77M | $-140M | $320M | $89M | $13M | $37M | $-97M | $-76M | $336M | $150M | $-37M | $-14M | $9M | $9M | $-12M | $-53M | |
| Free Cash Flow | · | $-145M | · | · | · | $-107M | · | · | · | $-79M | · | · | $-47M | · | · | $-52M |
Redditività 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -20.7% | -13.4% | · | -13.2% | -14.3% | -18.6% | · | -19.9% | -12.1% | -16.2% | -23.8% | -21.9% | -13.1% | -10.8% | -13.0% | -8.1% | |
| ROE | -28.0% | -15.8% | · | -15.5% | -16.5% | -20.1% | · | -22.7% | -13.3% | -18.2% | -30.0% | -26.3% | -15.3% | -12.5% | -14.1% | -8.7% |
Liquidità e Solvibilità 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.0 | 19.9 | · | 13.5 | 16.8 | 20.4 | · | 17.0 | 26.6 | 21.8 | 5.7 | 10.5 | 11.5 | 11.1 | 11.6 | 14.8 | |
| Quick Ratio | 8.7 | 14.7 | · | 9.6 | 11.7 | 13.9 | · | 12.3 | 20.4 | 12.2 | 4.4 | 8.3 | 8.4 | 6.2 | 5.3 | 6.4 | |
| Interest Coverage | · | · | · | -39.2 | -1231.8 | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-518M | $-455M | · | $-431M | $-388M | $-343M | · | $-288M | $-256M | $-235M | $-211M | $-203M | $-173M | $-172M | $-160M | $-133M | |
| Market Cap | $3.68B | $3.00B | · | $1.80B | $1.09B | $1.19B | · | $3.65B | $3.53B | $2.47B | $549M | $686M | $672M | $659M | $355M | $498M | |
| P/E | -6.3 | -5.2 | · | -3.4 | -2.6 | -3.0 | · | -10.4 | -9.9 | -7.8 | -2.5 | -3.1 | -3.5 | -3.8 | -2.2 | · | |
| P/B | 5.2 | 3.5 | · | 2.6 | 1.9 | 1.8 | · | 5.2 | 4.6 | 5.2 | 3.6 | 3.3 | 2.8 | 2.6 | 1.2 | 1.5 | |
| P / Tangible Book | 5.2 | 3.5 | · | 2.6 | 1.9 | 1.8 | · | 5.2 | 4.6 | 5.2 | 3.6 | 3.3 | 2.8 | 2.6 | 1.2 | 1.5 | |
| P / Cash Flow | · | -20.7 | · | · | · | -11.2 | · | · | · | -31.5 | · | · | -14.3 | · | · | -9.8 | |
| P / FCF | · | -20.6 | · | · | · | -11.1 | · | · | · | -31.4 | · | · | -14.2 | · | · | -9.5 | |
| Earnings Yield | -15.9% | -19.4% | · | -29.6% | -38.7% | -33.7% | · | -9.6% | -10.1% | -12.9% | -40.7% | -32.6% | -28.5% | -26.2% | -45.3% | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utile netto | $-446M | $-317M | $-236M | $-168M | $-149M |
| EPS Diluito | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 22.3 | 15.6 | 2.5 | 9.5 | 13.3 |
| Quick Ratio | 17.6 | 10.3 | 2.4 | 6.1 | 7.0 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-405M | $-295M | $-189M | $-157M | $-123M |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 262 filer · $2.5B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 54 (+12 vs trimestre precedente) | 27 (-14 vs trimestre precedente) | 87 (-11 vs trimestre precedente) | 70 (+7 vs trimestre precedente) | +3.8M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| STATE STREET CORP | $165.648.021 | 7.458.263 | 6,74% | Azioni |
| FMR LLC | $160.201.907 | 7.213.053 | 6,52% | Azioni |
| Orbis Allan Gray Ltd | $155.111.575 | 6.983.862 | 6,31% | Azioni |
| Atlas Venture Life Science Advisors, LLC | $151.030.199 | 6.800.099 | 6,14% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $140.166.621 | 6.310.969 | 5,70% | Azioni |
| TCG Crossover Management, LLC | $102.502.348 | 4.615.144 | 4,17% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $89.915.586 | 4.048.428 | 3,66% | Azioni |
| Vestal Point Capital, LP | $74.958.750 | 3.375.000 | 3,05% | Azioni |
| ORBIMED ADVISORS LLC | $71.864.542 | 3.235.684 | 2,92% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $71.309.878 | 3.209.934 | 2,90% | Azioni |
| Frazier Life Sciences Management, L.P. | $70.029.951 | 3.153.082 | 2,85% | Azioni |
| ARMISTICE CAPITAL, LLC | $68.567.289 | 3.087.226 | 2,79% | Azioni |
| PERCEPTIVE ADVISORS LLC | $59.727.909 | 2.689.235 | 2,43% | Azioni |
| Logos Global Management LP | $56.635.500 | 2.550.000 | 2,30% | Azioni |
| Venrock Adviser, LLC | $48.282.608 | 2.173.913 | 1,96% | Azioni |
| Siren, L.L.C. | $47.287.866 | 2.129.125 | 1,92% | Azioni |
| MPM BIOIMPACT LLC | $42.689.686 | 1.922.093 | 1,74% | Azioni |
| GOLDMAN SACHS GROUP INC | $41.625.071 | 1.874.159 | 1,69% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $40.865.556 | 1.839.962 | 1,66% | Azioni |
| Sofinnova Investments, Inc. | $36.832.709 | 1.658.384 | 1,50% | Azioni |
| Palo Alto Investors LP | $36.591.441 | 1.647.521 | 1,49% | Azioni |
| Vivo Capital, LLC | $34.591.320 | 1.557.466 | 1,41% | Azioni |
| Aberdeen Group plc | $34.190.829 | 1.539.434 | 1,39% | Azioni |
| Deep Track Capital, LP | $33.315.000 | 1.500.000 | 1,35% | Azioni |
| BANK OF AMERICA CORP /DE/ | $31.725.719 | 1.428.443 | 1,29% | Azioni |
| FCPM III SERVICES B.V. | $31.679.678 | 1.426.370 | 1,29% | Azioni |
| Polar Capital Holdings Plc | $28.580.072 | 1.286.811 | 1,16% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $26.700.929 | 1.202.203 | 1,09% | Azioni |
| CITADEL ADVISORS LLC | $25.407.307 | 1.143.958 | 1,03% | Azioni |
| Saturn V Capital Management LP | $23.486.920 | 1.057.493 | 0,96% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $21.964.557 | 988.949 | 0,89% | Azioni |
| NOVO HOLDINGS A/S | $21.330.351 | 960.394 | 0,87% | Azioni |
| Rock Springs Capital Management LP | $20.925.240 | 942.154 | 0,85% | Azioni |
| BRAIDWELL LP | $20.468.692 | 921.598 | 0,83% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $19.414.605 | 874.138 | 0,79% | Azioni |
| BAKER BROS. ADVISORS LP | $18.066.702 | 813.449 | 0,73% | Azioni |
| SAMLYN CAPITAL, LLC | $14.875.658 | 669.773 | 0,60% | Azioni |
| Artisan Partners Limited Partnership | $14.653.847 | 659.786 | 0,60% | Azioni |
| TD Asset Management Inc | $12.173.568 | 548.112 | 0,50% | Azioni |
| ALGERT GLOBAL LLC | $11.244.323 | 506.273 | 0,46% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $9.591.389 | 431.850 | 0,39% | Azioni |
| Clearbridge Investments, LLC | $9.220.070 | 415.131 | 0,37% | Azioni |
| ArrowMark Colorado Holdings LLC | $8.822.278 | 397.221 | 0,36% | Azioni |
| MPM ASSET MANAGEMENT LLC | $8.632.056 | 682.376 | 0,35% | Azioni |
| WASATCH ADVISORS LP | $8.043.701 | 443.668 | 0,33% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $8.008.304 | 360.572 | 0,33% | Azioni |
| Tetragon Partners GP Ltd | $7.921.352 | 356.657 | 0,32% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $7.905.716 | 355.953 | 0,32% | Azioni |
| Granahan Investment Management, LLC | $7.519.529 | 338.565 | 0,31% | Azioni |
| University of Wisconsin Foundation | $6.964.146 | 313.559 | 0,28% | Azioni |
| MOORE CAPITAL MANAGEMENT, LP | $6.791.685 | 305.794 | 0,28% | Azioni |
| Squarepoint Ops LLC | $6.664.644 | 300.074 | 0,27% | Azioni |
| Fisher Asset Management, LLC | $6.629.795 | 298.505 | 0,27% | Azioni |
| AMERIPRISE FINANCIAL INC | $6.625.622 | 298.317 | 0,27% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $6.468.951 | 291.263 | 0,26% | Azioni |
| Ensign Peak Advisors, Inc | $6.434.903 | 289.730 | 0,26% | Azioni |
| Alyeska Investment Group, L.P. | $5.447.624 | 245.278 | 0,22% | Azioni |
| Catalio Capital Management, LP | $5.439.873 | 244.929 | 0,22% | Azioni |
| Swiss National Bank | $5.152.720 | 232.000 | 0,21% | Azioni |
| SPHERA FUNDS MANAGEMENT LTD. | $4.432.983 | 199.594 | 0,18% | Azioni |
| SummitTX Capital, L.P. | $4.323.021 | 194.643 | 0,18% | Azioni |
| RHUMBLINE ADVISERS | $4.082.158 | 183.799 | 0,17% | Azioni |
| CITIGROUP INC | $3.998.733 | 180.042 | 0,16% | Azioni |
| HighVista Strategies LLC | $3.819.254 | 171.961 | 0,16% | Azioni |
| ALPS ADVISORS INC | $3.710.891 | 167.082 | 0,15% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $3.469.269 | 156.203 | 0,14% | Azioni |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.467.781 | 156.136 | 0,14% | Azioni |
| AXXCESS WEALTH MANAGEMENT, LLC | $3.448.547 | 155.270 | 0,14% | Azioni |
| Darwin Wealth Management, LLC | $3.448.546 | 155.270 | 0,14% | Azioni |
| Aegis Wealth Management LLC | $3.332.166 | 150.030 | 0,14% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3.331.500 | 150.000 | 0,14% | Azioni |
| Woodline Partners LP | $3.317.907 | 149.388 | 0,13% | Azioni |
| BlackRock, Inc. | $3.223.182 | 145.123 | 0,13% | Azioni |
| Bank of New York Mellon Corp | $3.129.789 | 140.918 | 0,13% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $3.119.810 | 172.080 | 0,13% | Azioni |
| Schonfeld Strategic Advisors LLC | $2.992.841 | 134.752 | 0,12% | Azioni |
| XTX Topco Ltd | $2.793.707 | 125.786 | 0,11% | Azioni |
| Jain Global LLC | $2.583.934 | 116.341 | 0,11% | Azioni |
| Rafferty Asset Management, LLC | $2.556.415 | 115.102 | 0,10% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.532.090 | 139.663 | 0,10% | Azioni |
| MORGAN STANLEY | $2.460.571 | 110.786 | 0,10% | Azioni |
| AXA Investment Managers S.A. | $2.064.872 | 163.231 | 0,08% | Azioni |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $1.933.798 | 87.069 | 0,08% | Azioni |
| JANUS HENDERSON GROUP PLC | $1.810.516 | 99.863 | 0,07% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.804.296 | 81.238 | 0,07% | Azioni |
| MetLife Investment Management, LLC | $1.771.803 | 79.775 | 0,07% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.746.195 | 78.622 | 0,07% | Azioni |
| FIFTH THIRD BANCORP | $1.684.826 | 75.859 | 0,07% | Azioni |
| CIBC WORLD MARKET INC. | $1.683.140 | 75.783 | 0,07% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.548.081 | 69.702 | 0,06% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $1.478.808 | 66.583 | 0,06% | Azioni |
| VANGUARD GROUP INC | $1.433.904 | 73.308 | 0,06% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.395.321 | 62.824 | 0,06% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.390.346 | 62.600 | 0,06% | Opzione Put |
| JANE STREET GROUP, LLC | $1.377.020 | 62.000 | 0,06% | Opzione Put |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1.309.213 | 58.947 | 0,05% | Azioni |
| PROFUND ADVISORS LLC | $1.306.170 | 58.810 | 0,05% | Azioni |
| Invesco Ltd. | $1.212.555 | 54.595 | 0,05% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $1.210.400 | 54.498 | 0,05% | Azioni |
| Vanguard Global Advisers, LLC | $1.202.383 | 54.137 | 0,05% | Azioni |
Insider aziendali 26 insider · 7 dirigenti · 10 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joshua T Brumm | CEO & President | 11 Marzo 2024 M | 537.998 | 0 | 0 | $0 |
| Susanna Gatti High | Chief Operating Officer | 18 Settembre 2024 S | 131.636 | 0 | 0 | $0 |
| Oxana Beskrovnaya | Chief Scientific Officer | 11 Marzo 2025 S | 195.840 | 0 | 0 | $0 |
| Richard William Scalzo | SVP, Head of Finance & Admin. | 11 Marzo 2025 S | 122.330 | 0 | 0 | $0 |
| Wildon Farwell | Chief Medical Officer | 19 Agosto 2024 S | 143.222 | 0 | 0 | $0 |
| Jonathan Mcneill | Chief Business Officer | 19 Agosto 2024 S | 132.106 | 0 | 0 | $0 |
| Romesh Subramanian | Chief Scientific Officer | 16 Settembre 2020 A | 566.249 | 0 | 0 | $0 |
| Dirk Kersten | Direttore | 27 Luglio 2026 S | 3.586.796 | 0 | 19 | $-38.570.974 |
| Barry E Greene | Direttore | 22 Giugno 2026 A | — | 0 | 0 | $0 |
| Carlo Incerti | Direttore | 05 Giugno 2026 A | 0 | 0 | 0 | $0 |
| Catherine Stehman-Breen | Direttore | 05 Giugno 2026 A | 115.713 | 0 | 0 | $0 |
| David Charles Lubner | Direttore | 05 Giugno 2026 A | 0 | 0 | 0 | $0 |
| Brian S Posner | Direttore | 05 Giugno 2026 A | 24.500 | 7 | 0 | $274.840 |
| Edward Hurwitz | Direttore | 05 Giugno 2026 A | 91.081 | 0 | 0 | $0 |
| Vikram Karnani | Direttore | 22 Dicembre 2025 A | — | 0 | 0 | $0 |
| Lawrence Otto Klein | Direttore | 05 Luglio 2022 A | 10.725 | 0 | 0 | $0 |
| Atlas Venture Fund XI, L.P. | Proprietario del 10% | 13 Luglio 2021 J | 7.326.117 | 0 | 0 | $0 |
| CureDuchenne Ventures, LLC | Proprietario del 10% | 21 Settembre 2020 C | 602.972 | 0 | 0 | $0 |
| Forbion Capital Fund IV Cooperatief U.A. | Proprietario del 10% | 21 Settembre 2020 C | 6.131.079 | 0 | 0 | $0 |
| Logos Global Management LP | Proprietario del 10% | 21 Settembre 2020 C | 1.504.392 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Proprietario del 10% | 21 Settembre 2020 C | 1.608.785 | 0 | 0 | $0 |
| Jason P Rhodes | — | 14 Agosto 2026 S | 428.946 | 0 | 31 | $-99.402.433 |
| Johanna Friedl-Naderer | — | 13 Agosto 2026 S | 153.982 | 0 | 7 | $-31.766 |
| Douglas Kerr | — | 13 Agosto 2026 S | 167.599 | 0 | 7 | $-176.412 |
| Erick Lucera | — | 13 Agosto 2026 S | 119.766 | 0 | 4 | $-228.675 |
| John Cox | — | 13 Agosto 2026 S | 363.165 | 0 | 5 | $-336.865 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Vida Ventures II, LLC, Vida Ventures II-A, LLC, VV Manager II, LLC ×2 depositi | 10 Febbraio 2023 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 52 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,67% | 14.322 NS | 30 Aprile 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,67% | 4.266 NS | 30 Aprile 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,67% | 196.941 NS | 30 Aprile 2026 | N-PORT |
| ESSC · Strategy Shares | 0,18% | 2.581 NS | 30 Aprile 2026 | N-PORT |
| BIB · ProShares Trust | 0,16% | 6.087 NS | 31 Maggio 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 51.630 NS | 30 Aprile 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,10% | 4.423 NS | 30 Aprile 2026 | N-PORT |
| RSSL · Global X Funds | 0,07% | 57.752 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 6.271 NS | 31 Maggio 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,06% | 688.953 NS | 31 Maggio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,05% | 390.218 NS | 30 Aprile 2026 | N-PORT |
| UWM · ProShares Trust | 0,04% | 4.905 NS | 31 Maggio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 53.716 NS | 30 Aprile 2026 | N-PORT |
| URTY · ProShares Trust | 0,03% | 4.964 NS | 31 Maggio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 25.564 NS | 30 Aprile 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 4.701 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 125 NS | 31 Maggio 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 44.010 NS | 31 Maggio 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 11.272 NS | 31 Maggio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 9.076 NS | 30 Aprile 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 123.282 NS | 30 Aprile 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 84.436 NS | 31 Maggio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 21.333 NS | 30 Aprile 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 720 NS | 30 Aprile 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 33.452 NS | 30 Aprile 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 5.252 NS | 31 Maggio 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0,03% | -43.244 NS | 30 Aprile 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VBR · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 Luglio 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| ITOT · iShares Trust | — | — | 05 Agosto 2026 | Giornaliero |
| IWV · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | — | — | 17 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IBB · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 23 Luglio 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | — | — | 20 Luglio 2026 | Giornaliero |
| ISCB · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| ISCG · iShares Trust | — | — | 06 Agosto 2026 | Giornaliero |
| ISCV · iShares Trust | — | — | 05 Agosto 2026 | Giornaliero |
| SMLF · iShares Trust | — | — | 10 Agosto 2026 | Giornaliero |
| ESML · iShares Trust | — | — | 14 Agosto 2026 | Giornaliero |
| IBRN · iShares Trust | — | — | 06 Agosto 2026 | Giornaliero |